Literature DB >> 26067983

Zonular Dehiscence at the Time of Combined Vitrectomy and Cataract Surgery After Intravitreal Ocriplasmin Injection.

Johannes Keller1, Richard J Haynes1.   

Abstract

Entities:  

Mesh:

Substances:

Year:  2015        PMID: 26067983     DOI: 10.1001/jamaophthalmol.2015.1680

Source DB:  PubMed          Journal:  JAMA Ophthalmol        ISSN: 2168-6165            Impact factor:   7.389


× No keyword cloud information.
  5 in total

1.  Real world outcomes of ocriplasmin use by members of the British and Eire Association of Vitreoretinal Surgeons.

Authors:  R J Haynes; D Yorston; D A H Laidlaw; J Keller; D H W Steel
Journal:  Eye (Lond)       Date:  2016-09-02       Impact factor: 3.775

Review 2.  Ocriplasmin use for vitreomacular traction and macular hole: A meta-analysis and comprehensive review on predictive factors for vitreous release and potential complications.

Authors:  Irini Chatziralli; George Theodossiadis; Paraskevi Xanthopoulou; Michael Miligkos; Sobha Sivaprasad; Panagiotis Theodossiadis
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  2016-04-30       Impact factor: 3.117

Review 3.  Ocriplasmin: who is the best candidate?

Authors:  Claudia M Prospero Ponce; William Stevenson; Rachel Gelman; Daniel R Agarwal; John B Christoforidis
Journal:  Clin Ophthalmol       Date:  2016-03-17

Review 4.  Optimal management of idiopathic macular holes.

Authors:  Haifa A Madi; Ibrahim Masri; David H Steel
Journal:  Clin Ophthalmol       Date:  2016-01-13

5.  OCRIPLASMIN FOR VITREOMACULAR TRACTION IN CLINICAL PRACTICE: The INJECT Study.

Authors:  David H W Steel; Niall Patton; Theodor Stappler; Niral Karia; Hans Hoerauf; Nishal Patel; Joachim Wachtlin; Thomas Raber; Petra Kozma-Wiebe
Journal:  Retina       Date:  2021-02-01       Impact factor: 3.975

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.